Events

ARLG Experts Are Training the Next Generation of Researchers in Clinical Trials for Infectious Diseases

Posted on by AM

In November, ARLG members Drs. Angela Huttner, David Paterson, and Tom Holland will be leading engaging presentations and interactive workshops in an ESCMID postgraduate course, alongside other renowned experts in the field of infectious diseases and microbiology.

Course Title: Clinical trials in infectious diseases: from generating the initial idea to reporting final results and everything in between
Date: November 19-21, 2026
Location: Valleta, Malta
Registration & Grant Application Deadline: September 28, 2026

This three-day workshop is ideal for clinicians, trainees, and scientists in the fields of infectious diseases and microbiology with no or minimal clinical trials experience. The comprehensive course is designed to guide participants through every stage of clinical trial development, from generating innovative ideas and securing funding, to analyzing results and publishing study findings.

This is the first course to be offered through the CLARITY Initiative which aims to improve the generation and interpretation of evidence through clinical research in infectious diseases and clinical microbiology. The CLARITY Initiative is supported by a partnership with the ARLG and other infectious diseases organizations.

An ESCMID Attendance Grant is available to cover the registration fee for 12 participants.

Visit the ESCMID postgraduate course webpage to learn more and register for this opportunity to gain hands-on experience to design and conduct impactful clinical trials.

ARLG at IDWeek 2025

Posted on by AM

IDWeek 2025 is here! Whether you’re attending in person in Atlanta, GA or online, you can hear some of ARLG’s top leaders and experts discuss the latest AMR topics.

You won’t want to miss this year’s SHEA Lectureship, which was awarded to ARLG’s Mentoring Committee Chair, Anthony Harris, MD, MPH. This award recognizes his important contributions to the fields of health care epidemiology, infection prevention, and antimicrobial stewardship through his leadership and mentorship. Dr. Harris will give his lecture, “Where is the true north of infection control?” on Tuesday, October 21 at 4:45 p.m. ET.

Check out the ARLG member sessions and presentations in the tables below, or view the full schedule and on-demand content at IDWeek.org.

Sessions

DayTime (ET)Session TitlePresentation TitleModeratorsSpeakers
10/19/202510:45 - 11:30 amPW07 – Expanding Your Influence to Improve Antibiotic Use in Outpatient Settings Advancing Outpatient Stewardship in Health SystemsRitu Banerjee
10/19/202510:50 am - 12:15 pmPW04 – Fellows’ Day WorkshopCareers in ResearchCesar Arias
10/19/20252:40 – 3:15 pm2 – Beyond the 101: Pondering Perplexing Prescribing IssuesCan We Use Ceftriaxone Susceptibility to Interpret Susceptibility to Third-Generation Cephalosporins?Pranita Tamma
10/19/20253:45 – 5:30 pm8 – Opening Plenary: Reflection and Renewal: Advancing Public Health in Challenging TimesYohei Doi
10/20/20258:00 – 9:00 am15 – New Antimicrobials in the PipelineDavid van Duin
10/20/20258:00 – 8:30 am17 – These Blind Mice: When Bench Doesn’t Meet Bedside Optimizing Dosing Strategies: Insights From Systems Pharmacology and Experimental ModelsGauri Rao
10/20/20258:00 – 9:00 am18 – Top 10 Papers in Antimicrobial ResistanceYohei Doi
10/20/202510:55 - 11:20 am24 – Applying Next-Generation Sequencing to Clinical Treatment and PreventionCases in Genotype-Phenotype in the Microbiology Laboratory: What Clinician Need to KnowAmy Mathers
10/20/202510:30 - 11:45 am25 – Blood and Guts: Microbiome DiscoveriesDavid van Duin
10/20/202510:30 - 11:45 am30 – Lessons Learned in Biopreparedness and Biocontainment: Lassa Fever in the MidwestYohei Doi
10/20/20252:21 – 2:39 pm64 – Out With the Old, in With the New: Time to Update the Management of Staphylococcus aureus infectionsShould Ceftobiprole Replace Ceftaroline in the Management of Persistent Staphylococcal Bacteremia?Nicholas Turner
10/20/20251:45 – 3:00 pm 72 – Late Breaking Trial Results for Viral and Bacterial InfectionsYohei Doi
10/20/20253:15 – 4:30 pm 84 – Diagnostic Clinical Cases: What Do I Do With This Test Result?Ritu Banerjee
10/20/20253:15-4:30 pm87 – Extra, Extra New Info on Treating and Preventing RSV and InfluenzaAngelique Boutzoukas
10/20/20253:15-4:30 pm88 – New Anti-Infective AgentsPranita Tamma
10/20/20253:15-4:30 pm84 – Commonalities and Differences in Antimicrobial Treatment of Resistant PathogensYohei Doi
10/21/20258:00 – 9:00 am99 – Diagnostic Trials: Past and FutureRobin Patel, Ritu Banerjee
10/21/20258:00 – 8:30 am99 – Diagnostic Trials: Past and FutureEvaluation of Infectious Disease Diagnostics: Innovative Study Designs to Assess Test PerformanceMichael Satlin
10/21/20258:30 – 9:00 am99 – Diagnostic Trials: Past and FutureEvaluation of Infectious Disease Diagnostics: Study Designs to Assess Impact on Clinical OutcomesSarah Doernberg
10/21/20258:00 – 9:00 am104 – Pediatric Antimicrobial Resistance: Key Updates for the Busy ClinicianLatania Logan, Pranita Tamma
10/21/20258:30 – 9:00 am104 – Pediatric Antimicrobial Resistance: Key Updates for the Busy ClinicianUpdates in Gram-Negative BacteriaAngelique Boutzoukas
10/21/20259:15 -10:00 am107 – Maxwell Finland LectureYohei Doi
10/21/20259:35 -10:00 am107 – Maxwell Finland LectureAntimicrobial Resistance at the Bedside: Translating Science into Patient OutcomesCesar Arias
10/21/20251:45 – 3:00 pm157 – Cavities, Appys, and CLABSis, Oh My! Perspectives From Our Surgery and Radiology ColleaguesLatania Logan
10/21/20251:45 – 3:00 pm162 – Fresh New Results On Old and New VaccinesAhmed Babiker
10/21/20251:45 – 3:00 pm163 – Lowering Barriers to Diagnostics Access to Reduce Health Inequalities and Improve OutcomesRitu Banerjee
10/21/20253:15 – 4:30 pm171 – New Antibiotics, Untapped Potential: Exploring the Underuse of Recently Approved AgentsThomas Lodise
10/21/20254:05 – 4:30 pm172 – Bug to Drug: Translating Mechanisms of Antimicrobial Resistance to Treatment of Challenging InfectionsTranslational Antimicrobial Resistance Research in Low-Resource SettingsJose Munita
10/21/20253:15 – 4:30 pm173 – Challenging Cases in Immunocompromised HostMichael Satlin (panelist)
10/21/20255:25 – 5:55 pm183 – SHEA LectureshipWhere is the True North of Infection Control?Anthony Harris
10/21/20254:45 – 6:00 pm184 – Stanley A. Plotkin Lecture in VaccinologyLatania Logan
10/22/20258:00 –8:20 am191 – One Size Fits One: Toward Individualized Management of Infectious DiseasesMolecular Diagnostics to Refine Duration of Therapy for Blood Stream Infection: S. aureusVance Fowler
10/22/202510:30 -10:55 am197 – Clinical Trials That Will Change Your PracticeTrials in Bacteriology That May Change Your PracticeAmy Mathers
10/22/20251:45-3:00 pm241 – Advances in Managing Antimicrobial ToxicitiesAmit Pai
10/22/20253:15 – 4:30 pm257 – Cracking the Code of Resistance: A Deep Dive Into Metallo-Beta-Lactamase From Bench to BedsideYohei Doi, Amy Mathers
10/22/20253:15 – 3:40 pm257 – Cracking the Code of Resistance: A Deep Dive Into Metallo-Beta-Lactamase From Bench to BedsideUnmasking Resistance: Epidemiology and Diversity of MBLsMaria Mojica
10/22/20253:15 – 4:30 pm259 – Driving Better Decisions: Incentivizing Diagnostic StewardshipRitu Banerjee
10/22/20253:15 – 4:30 pm266 – Why Do We Do This? Exploring the Data Behind Long-Established Practices in IDDouble Coverage; Do We Need It?Kerry LaPlante

Posters & Oral Presentations

DayTime (ET)TitlePresenting AuthorAuthors
10/20/202511:18 – 11:30 am78 – Oral Presentation: Aerobactin Gene iuc as a Virulence Marker Associated with Increased Mortality in Carbapenem-Resistant Klebsiella pneumoniae infections: A Multicenter Observational Cohort Study from ChinaJianping JiangJiang JJ, Li Y, Komarow L, Boutzoukas A, Yu Y, Xiao Y, Gao H, Liu Z, Fowler Jr VG, Kreiswirth BN, Chen L, Wang M, van Duin D, for the Antibacterial Resistance Leadership Group
10/20/202512:15-1:30 pmP-476 – Poster Presentation: Risk Factors for Mortality in Children and Young Adults with Carbapenem-Resistant Gram-Negative InfectionsAngelique BoutzoukasBoutzoukas AE, Tian J, Komarow L, Ge L, Wang M, Arias C, Guttierrez JMO, Alenazi T, Liu Z, Paterson D, Satlin M, Doi Y, Fowler V, van Duin D
10/21/202512:15 – 1:30 pmP-1292 – Poster Presentation: Clinical and Genomic Features of Colistin Resistance Among Carbapenem-resistant Acinetobacter baumannii Isolated From Global Clinical SamplesMadison StellfoxStellfox ME, Komarow L, Patel R, van Duin D, Van Tyne D, Doi Y
10/21/202512:15 – 1:30 pmP-1296 – Poster Presentation:
Impact of Metallo-Beta Lactamases on Outcomes in Patients with Carbapenem-Resistant Gram-Negative Infections		Angelique BoutzoukasBoutzoukas AE, Shao W, Jiang J, Kanj S, Wang M, Salcedo Mendoza S, Marimuthu K, Liu Z, Komarow L, Fowler V, Kreiswirth B, Arias C, Doi Y, Paterson D, Satlin M, Bonomo R, van Duin D
10/21/202512:15 – 1:30 pmP-1302 – Poster Presentation:
Klebsiella pneumoniae Phage Susceptibility Testing (PST): Comparison Between a Spot Plaque Assay and an Optical Density-Based Liquid Assay		Luz CuelloCuello L, Patel R
10/22/202510:45 – 11:00 am556 – Oral Presentation:
Using a novel Anaerobic Activity Index to assess risk for poor outcomes in burn patients in a burn intensive care unit		Natalie MackowMackow NA, Komarow L, Napravnik S, Bartelt L, DiBiase LM, Williams B, Williams FN, Weber DJ, van Duin D

 

ESCMID Global 2025

Posted on by AM

Every year, the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) brings together experts in infectious diseases and clinical microbiology, including many ARLG members. ESCMID Global 2025 is being held on April 11-15 in Vienna, Austria, with live streaming of sessions for virtual attendees. Check out the list below of ARLG members who are speaking or chairing events. The full schedule with more details about each of these sessions is available on the ESCMID Global 2025 website.

Friday, April 11

Time (CEST) Session Title ARLG Member
8:30-10:30 Special Session (SP1): Antimicrobial Stewardship in Different Scenarios Co-Chair: Angela Huttner
16:15-18:15 Educational Session (EW027): Going Viral! Phage Therapy Clinical Rounds Speaker: Ghady Haidar

Saturday, April 12

Time (CEST) Session Title ARLG Member
11:00-12:00 Oral Session (OS013): Viral Challenges in Organ Transplantation Co-Chair: Ghady Haidar
11:00-12:00 Keynote (KN044): Asia: An AMR Hot Zone Speaker: David Paterson
16:15-18:15 Educational Session (EW071): The Rare Art of Writing Scientific Articles: From Conception to Submission Speaker: Angela Huttner
16:15-18:15 Late-Breakers Oral Session (LB006): The Trial Run: Recent Trials on S. aureus Bacteremia Management Co-Chair: Vance Fowler

Sunday, April 13

Time (CEST) Session Title ARLG Member
13:30-15:30 Special Session (SEL): Selective Pressure Co-Chair: David van Duin
13:30-14:30 Journal Session (JS1): Late-Breaker Research from CMI and CMI Communications Speaker: Thomas Holland
16:15-17:15 Symposia (SY104): Targeted vs. Standard Perioperative Prophylaxis in Solid Organ Transplant with MDR Gram-Negative Colonisation Co-Chair: David van Duin
16:15-17:15 Symposia (SY105): Novel Beta-Lactams and Beta-Lactamase Inhibitors: A Diagnostic and Therapeutic Approach Co-Chair: Robert Bonomo

Monday, April 14

Time (CEST) Session Title ARLG Member
8:30-10:30 Educational Session (EW119): This Bacterium Might Harbour AmpC, What Should I Do?! Co-Chair: Pranita Tamma
Speaker: Amy Mathers
11:00-12:00 Flash e-Poster Session (EF090): Addressing the Need for Speed: Advances in Point-of-Care Testing Chair: Jennifer Dien Bard
13:30-14:30 Symposia (SY132): Predicting Antibiotic Susceptibility Profiles from Whole Genome Sequences: State-of-the-Art Speaker: Patricia Simner
14:45 – 15:45 Pipeline Symposium (PM4): Do We Need New Antibiotics? Co-Chair: Angela Huttner
16:15-17:15 Oral Session (OS102): AI Tools Empowering AMR Prediction in WGS and MALDI-TOF Co-Chair: Patricia Simner
16:15-18:15 Pipeline Symposium (PM5): Innovation in Direct from Blood Detection of BSI Co-Chair: Robin Patel

Tuesday, April 15

Time (CEST) Session Title ARLG Member
8:30-10:30 Educational Session (EW156): The Rules of the Game: How to Tackle the Peer-Review and Publication Process Speaker: Angela Huttner
8:30-10:30 Clinical Grand Round (CGR) David Paterson
(Expert Panel Member)
11:00-12:00 Meet the Expert (ME166): Implementing AI in Microbiological Diagnostics: Practical Steps and Quality Control Speaker: Jennifer Dien Bard
13:30-14:30 Flash e-Poster Session (EF131): The Current Landscape of Carbapenem Resistance: From Genotype to Phenotype and Virulence Determinants Chair: Amy Mathers

 

ARLG at ECCMID 2023

Posted on by susan.herron@duke.edu

Mark your calendars for the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), happening online and in Copenhagen, Denmark from April 15 – 18.

All sessions will be available on-demand through the ECCMID 2023 online platform until October 18, 2023. To help you plan, we’ve highlighted some sessions below you won’t want to miss.

 

Date Time (CEST) Session # and Title Presentation Title Speaker Chair
4/15/2023 13:30-14:30 SY041: Hot topics in prosthetic joint infections PJI: Pathogenesis, diagnosis, and novel treatment approaches Robin Patel
4/16/2023 16:15-18:15 SY064: Optimising the diagnosis and treatment of difficult-to-treat cardiovascular infection Diagnostic criteria for infective endocarditis 2023 Vance Fowler
4/16/2023 11:00-12:00 ME099: Meet-the-Expert: Why is it still so complex? How I treat persistent neutropenic fever David van Duin
4/16/2023 13:30-14:30 SEL1: Selective Pressure: Quiz Show-Pre-round David van Duin
4/16/2023 14:45-15:45 SEL2: Selective Pressure: Quiz Show- Semi-final and final David van Duin
4/16/2023 14:45-15:45 OS127: Challenges and advances in skin, soft tissue, bone and joint infections Robin Patel
4/17/2023 8:30-10:30 SY151: Responsible publishing in CM/ID Bad behavior and practice David van Duin

 

ECCMID 2022 On-Demand

Posted on by susan.herron@duke.edu

Catch ECCMID 2022 while you still can! Your registration includes access to on-demand content until July 26, 2022. To help you plan, we’ve highlighted some presentations and speakers you won’t want to miss. Also, mark your calendars for May 19, 2022. Post-ECCMID online learning day, which is on the topic of Antimicrobial Resistance and Stewardship, is free for ECCMID registrants. View the Post-ECCMID Programme

Attend ECCMID 2022 On-Demand

DayTime (CEST)Session # and TitlePresentation # and TitleSpeakers
April 2316:15-18:15EW053 Educational Workshop
Opportunistic infections of the central nervous system		WO219 Infections of the CNS in solid organ transplant patientsJudith Anesi
April 257:15-8:15 ME125 Meet the Expert
ESCMID and IDSA treatment guidelines for MDR Gram-negative bacterial infections		MO532 Pranita Tamma
April 258:30-10:30SY136 Symposium
ESCMID Guidelines for the treatment of infections caused by multidrug-resistant Gram-negatives: a case-based approach
SO583 Cases of multidrug-resistant P. aeruginosaRobert Bonomo
April 2513:30-14:30SY163 Symposium
Recent top papers in transplant ID and haem/onc ID		SO678 SOT-IDDavid van Duin
April 267:15-8:15ME189 Meet the Expert
Azole-resistant Candida parapsilosis: a new nosocomial threat?		MO776Mariana Castanheira
April 267:15-8:15ME191 Meet the Expert
Duration of therapy: from what we know to what we do		MO780 Angela Huttner
April 267:15-8:15ME194 Meet the Expert
How I treat severe Stenotrophomonas maltophilia infections		MO787David van Duin
April 2619:15-20:45 EW229 Educational Workshop Behavioural science essentials for antimicrobial stewardsWO937 Antibiotic prescribing as a decision-making processSara Cosgrove

ARLG at the Texas Medical Center AMR & Stewardship Conference

Posted on by susan.herron@duke.edu

ARLG experts will deliver presentations on a variety of topics during the 5th Annual Texas Medical Center AMR & Stewardship Conference. The event will take place online January 19 – 21. Use the guide below to help plan your conference sessions.

Register to Attend

ARLG AMR & Stewardship Conference 2022 Sessions

DayTimeSession TitlePresentation TitleModeratorsSpeakers
Jan. 197:30 - 8:20 a.m.Career Mentoring: Clinical Scientist PathwaySam Shelburne
Jan. 198:40 - 8:45 a.m.WelcomeCesar Arias
Jan. 198:45 - 9:10 a.m. ARLG and the Future of Clinical Research in Antimicrobial Resistance Vance Fowler
Jan. 193:30 - 4:30 p.m.Session 4: NIH Antimicrobial Resistance Leadership Group (ARLG) Early Stage Investigators Anthony Harris,
Henry Chambers
Jan. 193:30 - 4:45 p.m.DOOR analysis and cUTIJessica Howard-Anderson
Jan. 193:45 - 4:00 p.m.DOOR Endpoint Analysis in Intraabdominal Infection: FDA-NIH CollaborationTori Kinamon
Jan. 194:00 - 4:15 p.m.DOTS Trial: Dalbavancin as an Option for Treatment of Staphylococcus aureus BacteremiaNicolas Turner
Jan. 194:15 - 4:30 p.m.PHAGE TrialMaria Souli
Jan. 194:30 - 5:15 p.m.Session 5: Selected AbstractsSam Shelburne
Jan. 208:30 - 9:45 a.m.Session 6Blake Hanson
Jan. 208:30 - 8:55 a.m.Combination Therapies for Gram-negative BacteriaDavid van Duin
Jan. 202:00 - 3:00 p.m.Session 8Challenging Clinical Cases in Antimicrobial ResistanceCesar AriasSam Shelburne,
David van Duin
Jan. 203:00 - 4:00 p.m.Session 9: ARLG Session 2
Understanding the Enemy: Clinical and Microbiological Characterization of MDR Gram Negative Bacteria		Vance Fowler,
Helen Boucher
Jan. 203:00 - 3:15 p.m.Characterization of MDRO in South AmericaJinnethe Reyes
Jan. 203:15 - 3:30 p.m.SNAP InternationalYohei Doi
Jan. 203:30 - 3:45 p.m.POP InternationalMike Satlin
Jan. 203:45 - 4:00 p.m.SHRECDavid van Duin
Jan. 218:35 - 9:05 a.m. Session 11 Keynote: Dissecting Epidemics of Multidrug-resistant OrganismsKeynote: Dissecting Epidemics of Multidrug-resistant Organisms

Don’t miss this year’s PACCARD Public Meeting

Posted on by susan.herron@duke.edu

Make time November 30 — December 1 to attend the 2021 Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARD) public meeting. The virtual event will include updates from the Global Leaders Group (GLG) and the World Health Organization (WHO) on global efforts to combat Antimicrobial Resistance (AMR). The National Academies will also discuss their recent report about the long-term health and economic effects of AMR in the United States. Day two of the event will focus on addressing AMR in pandemic planning.

Review the full meeting agenda

To attend this event, be sure to REGISTER before the November 29 deadline.

 

ARLG at IDWeek 2021

Posted on by susan.herron@duke.edu

Make the most of IDWeek 2021! From Sept. 29 – Oct. 3, ARLG’s top leaders and experts will be discussing the latest AMR topics. Use the guide below to plan your conference sessions.

ARLG IDWeek 2021 Sessions

DayTimeSession TitlePresentation TitleModeratorsSpeakers
Sept. 29
4:00 - 5:15 p.m. Chasing the Sun: CTS-06 - COVID-19 IDSA Rapid Living Guidelines: Celebrations and ChallengesCOVID-19 diagnostic testing guidelinesKim Hanson
Sept. 297:00 - 8:00p.m.Chasing the Sun: CTS-08 - COVID-19 Update in JapanYohei Doi
Sept. 3011:00 a.m. - 12:15 p.m.04 - Case-based Guidelines SessionAntimicrobial Resistant Gram-Negative Infections: A Case Based ApproachPranita Tamma
Sept. 3011:00 a.m. - 12:15 p.m.04 - Case-based Guidelines SessionMolecular Diagnostics and Antigen Testing for COVID-19Angela Caliendo
Sept. 3011:00 a.m. - 12:15 p.m.05 - Diagnostic Clinical CasesChris Doern (panelist)
Sept. 3011:00a.m. - 12:15p.m. 12 - Hot issues in Enterococcus faecalis bacteremia/endocarditis (IE)Jose Miro
Sept. 3012:30 - 1:45 p.m.19 - Even More Bad Bugs (with Limited Drugs)Difficult-to-treat Resistance (DTR) Pseudomonas aeruginosaJessica Howard-Anderson
Sept. 3012:30 - 1:45 p.m.21 - Cardiovascular implantable electronic device (CIED) infectionsMicrobiological Diagnosis: Role of Advanced DiagnosticsJose MiroRobin Patel
Sept. 3012:30 - 1:45 p.m.26 - New Approaches to the Diagnosis of Lower Respiratory Tract InfectionsNext-generation Sequencing Approaches to Lower Respiratory Tract InfectionsPatricia (Trish) Simner
Sept. 303:45 - 5:00 p.m.43 – What’s New with VRETreatment of VRE Bacteremia: What You Need to KnowJulia MessinaJose Munita
Sept. 305:15 - 6:30 p.m.53 - Clinical Controversies in S. aureus BacteremiaOptimal Dosing of Antibiotics for S.aureus Bacteremia in Specific PopulationsTom HollandAmit Pai
Sept. 305:15 - 6:30 p.m.56 - Leading Teams During a CrisisManaging & Maintaining PrioritiesEbbing Lautenbach
Oct. 110:00 - 11:15 a.m.61 - Do breakpoints matter? The fungal storyBreakpoints in YeastMariana Castanheira
Oct. 111:30 a.m. - 12:45 p.m.750 - Challenging cases in Infectious DiseasesHenry Chambers (interactive moderator)
Oct. 111:30 a.m. - 12:45 p.m.79 - Top Practice-Changing Papers on Transplant IDTop Practice-changing Papers in Solid Organ TransplantJudith Anesi
Oct. 111:30a.m. - 12:45p.m85 - Public-private partnerships to revive future antibiotic development and accessYohei Doi
Oct. 12:45 - 4:00 p.m.90 - Therapeutic options for MDR gram-negativesYohei Doi (interactive moderator)David van Duin (panelist)
Oct. 12:45 - 4:00 p.m.92 - Successes in Outpatient StewardshipSara Cosgrove
Oct. 12:45 - 4:00p.m. 95 - Big Beasts of Skin & Soft Tissue InfectionsGram-Positive Necrotizing Soft Tissue InfectionsHenry Chambers
Oct. 12:45 - 4:00p.m. 101 - Update on natural and Prosthetic Vascular Graft InfectionsJose Miro
Oct. 12:45 - 4:00 p.m.102 - What's New in Orthopedic Infections: Bone Appetit!Going Viral: Phage Therapy for Orthopedic InfectionsGina Suh
Oct. 14:15 - 5:30p.m. 110 – Infectious Disease Consulting for Businesses During COVID-19: Tales from the Front LineCOVID-19 Consulting for the Entertainment IndustryAnthony Harris
Oct. 210:00 - 11:15 a.m.
127 - Pathogen-specific clinical trials: promise and practical considerationsGram-Negative Trials: Lessons LearnedYohei Doi Thomas Lodise
Oct. 21:15 - 3:00 p.m.133 - Clinical Trials That May Change Your PracticeJessica Howard-Anderson, Tom Holland

ARLG IDWeek 2021 Posters

NumberTitleAuthors
1219Unfavorable Clinical Outcomes with Polymyxins Compared to Ceftolozane/Tazobactam for the Treatment of Carbapenem-Resistant Pseudomonas aeruginosaHoward-Anderson J, Earley M, Hamasaki T, Bower CW, Smith G, van Duin D, Evans S, Jacob JT
1094Determination of Plasma Protein Binding of DalbavancinTurner NA, Xu A, Zaharoff S, Holland TL, Lodise TP on behalf of the Antibacterial Resistance Leadership Group